Macrocure IPO Info
Company Name: Macrocure
Stock Symbol: MCUR
Exchange: NASDAQ
Status: Priced
IPO Date: 7/31/2014
IPO Price:
10.00 (
-27.00%)
Underwriters
Credit Suisse and Jefferies & Co.
Amount of Offering: N/A
Number of Shares Offered: 5.35 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Macrocure Ltd. is a regenerative medicine company focused on developing, manufacturing and commercializing novel cell therapy products to address unmet needs in the treatment of chronic and other hard-to-heal wounds, such as diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). The Company's novel approach is to treat and close chronic and other hard-to-heal wounds by injecting the human body's own wound healing and regenerative components directly into the wound itself.
News Headlines
